Actionable news
All posts from Actionable news
Actionable news in ORMP: Oramed Pharmaceuticals Inc.,

Oramed to Present at Oppenheimer Annual Israeli Conference

Oramed Pharmaceuticals Inc. (ORMP) (, a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming Oppenheimer Annual Israeli Conference, taking place on May 22, 2016 in Tel Aviv. Nadav Kidron, CEO of Oramed, will present a corporate overview at the conference.

Presentation Details:

Oppenheimer 17th Annual Israeli Conference

Date: May 22, 2016
Presenter: Nadav Kidron, Chief Executive Officer
Time: 1:45 pm Israel Time
Location: David Intercontinental Hotel, Tel Aviv, Israel

About Oramed Pharmaceuticals
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, Oramed's Protein Oral Delivery (PODTM) technology is based on over 30 years of research by top scientists at Jerusalem's Hadassah Medical Center. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801). The Company completed multiple Phase II clinical trials under an Investigational New Drug application with the U.S. Food and Drug Administration. In addition, Oramed is developing an oral GLP-1 analog capsule (a>